北京大学学报(医学版) ›› 2019, Vol. 51 ›› Issue (5): 840-850. doi: 10.19723/j.issn.1671-167X.2019.05.009
孙建军1,△(),杨军1,谢京城1,常青2,马长城1,郑梅3,LIAO Hung-I4,王涛1,陈晓东1,韩芸峰1,林国中1,于涛1,张嘉1,司雨1
Jian-jun SUN1,△(),Jun YANG1,Jing-cheng XIE1,Qing CHANG2,Chang-cheng MA1,Mei ZHENG3,Hung-I LIAO4,Tao WANG1,Xiao-dong CHEN1,Yun-feng HAN1,Guo-zhong LIN1,Tao YU1,Jia ZHANG1,Yu SI1
摘要:
目的:对比性分析少节段和多节段髓内原发性肿瘤患者神经功能和预后的差异。方法: 选择北京大学第三医院2010年1月至 2015年12月显微神经外科手术治疗髓内肿瘤患者进行回顾性分析,共收集病例135例,用IJOA(improved Japanese orthopaedic association) 评分评估手术前后的神经功能状况。结果: 在少节段和多节段髓内肿瘤患者中,术前IJOA评分(P=0.02)和术后早期IJOA评分(P=0.004)差异均有统计学意义,不论术前还是术后早期,少节段髓内肿瘤患者神经功能都较好一些,大部分多节段髓内肿瘤患者都有不同程度的肢体无力,但是,对于术后长期的神经功能,多节段和少节段髓内肿瘤患者的差异无统计学意义(P=0.12),经过积极的功能锻炼,多节段髓内肿瘤患者的神经功能状况得以充分改善。结论:相比多节段髓内原发肿瘤患者,少节段髓内原发肿瘤患者围手术期的神经功能状况要好一些,尤其在肢体肌力方面,经积极功能锻炼,多节段髓内肿瘤患者的远期神经功能状况得以充分改善。
中图分类号:
[1] | Tobin MK, Geraghty JR, Engelhard HH , et al. Intramedullary spinal cord tumors: a review of current and future treatment strategies[J]. Neurosurg Focus, 2015,39(2):E14. |
[2] | Acerbi F, Cavallo C, Schebesch KM , et al. Fluorescein-guided resection of intramedullary spinal cord tumors: results from a preliminary, multicentric, retrospective study[J]. World Neurosurg, 2017,108(10):603-609. |
[3] | Montano N, Papacci F, Trevisi G , et al. Factors affecting functional outcome in patients with intramedullary spinal cord tumors: results from a literature analysis[J]. Acta Neurol Belg, 2017,117(1):277-282. |
[4] | Sun JJ, Wang ZY, Li ZD , et al. Microsurgical treatment and functional outcomes of multi-segment intramedullary primary spinal cord tumors[J]. J Clin Neurosci, 2009,16(5):666-671. |
[5] | Samuel N, Tetreault L, Santaguida C , et al. Clinical and pathological outcomes after resection of intramedullary spinal cord tumors: a single-institution case series[J]. Neurosurg Focus, 2016,41(2):E8. |
[6] | Sun JJ, Sun ZY, Li ZD , et al. Clinical analysis of the adolescent patients with multi-segments intramedullary spinal cord tumors[J]. Beijing Da Xue Xue Bao Yi Xue Ban, 2012,44(4):599-601. |
[7] | Wang ZY, Sun JJ, Xie JC , et al. Comparative analysis on the diagnosis and treatments of multi-segment intramedullary primary spinal cord tumors between the different age groups[J]. Neurosurg Rev, 2012,35(1):85-93. |
[8] | Ebner FH, Roser F, Falk M , et al. Management of intramedullary spinal cord lesions: interdependence of the longitudinal extension of the lesion and the functional outcome[J]. Eur Spine J, 2010,19(4):665-669. |
[9] | Ardeshiri A . Intramedullary spinal cord astrocytomas: the influence of localization and tumor extension on resectability and functional outcome[J]. Acta Neurochir, 2013,155(7):1203-1207. |
[10] | Sharma NC, Chandra T, Sharma A , et al. Long-segment intramedullary spinal dermoid[J]. India J Radiol Imaging, 2009,19(2):148-150. |
[11] | Bansal S, Ailawadhi P, Suri A , et al. Ten years’ experience in the management of spinal intramedullary tumors in a single institution[J]. J Clin Neurosci, 2013,20(2):292-298. |
[12] | Raco A, Esposito V, Lenzi J , et al. Long-term follow-up of intramedullary primary spinal cord tumors: a series of 202 cases[J]. Neurosurgery, 2005,56(5):972-981. |
[13] | Kutluk T, Varan A, Kafali C , et al. Pediatric intramedullary primary spinal cord tumors: a single center experience[J]. Eur J Paediatr Neurol, 2015,19(1):41-47. |
[14] | Chang UK, Choe WJ, Chung SK , et al. Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults[J]. J Neurooncol, 2002,57(2):133-139. |
[15] | Gavin QD, Farooqi N, Pigott TJ , et al. Outcome predictors in the management of spinal cord ependymoma[J]. Eur Spine J, 2007,16(3), 399-404. |
[16] | Moquin RR . Cystic intramedullary neoplasms of the spinal cord[J]. Semin Spine Surg, 2006,18(3):168-174. |
[17] | Xiao R . Molecular and clinical prognostic factors for favorable outcome following surgical resection of adult intramedullary spinal cord astrocytomas[J]. Clin Neurol Neurosurg, 2016,144(10):82-87. |
[18] | Sun JJ, Teo M, Wang ZY , et al. Characteristic and surgical results of multisegment intramedullary cervical spinal cord tumors[J]. Interdisciplinary Neurosurgery, 2017,7:29-43. |
[19] | Lee SM, Cho YE, Kwon YM . Neurological outcome after surgical treatment of intramedullary primary spinal cord tumors[J]. Korean J Spine, 2014,11(3):121-126. |
[20] | Fakhreddine MH, Mahajan A, Penas-Prado M , et al. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas[J]. Neuro Oncol, 2013,15(4):406-412. |
[21] | Kim MS, Chung CK, Choe GY , et al. Intramedullary spinal cord astrocytoma in adults: postoperative outcome[J]. J Neuro Oncol, 2001,52(1):85-94. |
[22] | Huddart R, Traish D, Ashley S , et al. Management of spinal astrocytoma with conservative surgery and radiotherapy. Br J Neurosurg, 1993,7(5):473-481. |
[23] | Yang S, Yang X, Hong G . Surgical treatment of one hundred seventy-four intramedullary primary spinal cord tumors[J]. Spine, 2009,34(24), 2705-2710. |
[24] | Abdullah KG, Lubelski D, Miller J , et al. Progression free survival and functional outcome after surgical resection of intramedullary ependymomas[J]. J Clin Neurosci, 2015,22(12):1933-1937. |
[25] | Behmanesh B, Setzer M, Konczalla J , et al. Management of patients with primary intramedullary spinal cord glioblastoma[J]. World Neurosurg, 2017,98(10):198-202. |
[26] | Jallo GI, Danish S, Velasquez L , et al. Intramedullary low-gradeastrocytomas: long-term outcome following radical surgery[J]. J Neurooncol, 2001,53(1):61-66. |
[27] | Abd-El-Barr MM, Huang KT, Chi JH . Infiltrating spinal cord astrocytomas: Epidemiology, diagnosis, treatments and future directions[J]. J Clin Neurosci, 2016,29(7):15-20. |
[28] | Venes J . Spinal cord astrocytoma: results of therapy[J]. Neurosurgery, 1992,30(4):490-493. |
[29] | Schebesch KM, Mueller S, Wendl C , et al. Recurrence rates and functional outcome after resection of intrinsic intramedullary tumors[J]. Clin Neurol and Neurosurg, 2015,134(4):60-66. |
[30] | Klekamp J . Treatment of intramedullary tumors: analysis of surgical morbidity and long-term results[J]. J Neurosurg Spine, 2013,19(1):12-26. |
[31] | Sandler HM, Papadopoulos SM, Thornton AF , et al. Spinal cord astrocytomas: results of therapy[J]. Neurosurgery, 1992,30(4):490-493. |
[1] | 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931. |
[2] | 欧俊永,倪坤明,马潞林,王国良,颜野,杨斌,李庚午,宋昊东,陆敏,叶剑飞,张树栋. 肌层浸润性膀胱癌合并中高危前列腺癌患者的预后因素[J]. 北京大学学报(医学版), 2024, 56(4): 582-588. |
[3] | 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630. |
[4] | 虞乐,邓绍晖,张帆,颜野,叶剑飞,张树栋. 具有低度恶性潜能的多房囊性肾肿瘤的临床病理特征及预后[J]. 北京大学学报(医学版), 2024, 56(4): 661-666. |
[5] | 周泽臻,邓绍晖,颜野,张帆,郝一昌,葛力源,张洪宪,王国良,张树栋. 非转移性T3a肾细胞癌患者3年肿瘤特异性生存期预测[J]. 北京大学学报(医学版), 2024, 56(4): 673-679. |
[6] | 方杨毅,李强,黄志高,陆敏,洪锴,张树栋. 睾丸鞘膜高分化乳头状间皮肿瘤1例[J]. 北京大学学报(医学版), 2024, 56(4): 741-744. |
[7] | 曾媛媛,谢云,陈道南,王瑞兰. 脓毒症患者发生正常甲状腺性病态综合征的相关因素[J]. 北京大学学报(医学版), 2024, 56(3): 526-532. |
[8] | 苏俊琪,王晓颖,孙志强. 舌鳞状细胞癌根治性切除术后患者预后预测列线图的构建与验证[J]. 北京大学学报(医学版), 2024, 56(1): 120-130. |
[9] | 李建斌,吕梦娜,池强,彭一琳,刘鹏程,吴锐. 干燥综合征患者发生重症新型冠状病毒肺炎的早期预测[J]. 北京大学学报(医学版), 2023, 55(6): 1007-1012. |
[10] | 刘欢锐,彭祥,李森林,苟欣. 基于HER-2相关基因构建风险模型用于膀胱癌生存预后评估[J]. 北京大学学报(医学版), 2023, 55(5): 793-801. |
[11] | 薛子璇,唐世英,邱敏,刘承,田晓军,陆敏,董靖晗,马潞林,张树栋. 青年肾肿瘤伴瘤栓的临床病理特征及预后分析[J]. 北京大学学报(医学版), 2023, 55(5): 802-811. |
[12] | 卢汉,张建运,杨榕,徐乐,李庆祥,郭玉兴,郭传瑸. 下颌牙龈鳞状细胞癌患者预后的影响因素[J]. 北京大学学报(医学版), 2023, 55(4): 702-707. |
[13] | 时云飞,王豪杰,刘卫平,米岚,龙孟平,刘雁飞,赖玉梅,周立新,刁新婷,李向红. 血管免疫母细胞性T细胞淋巴瘤临床与分子病理学特征分析[J]. 北京大学学报(医学版), 2023, 55(3): 521-529. |
[14] | 李挺. 建设当代临床病理学科[J]. 北京大学学报(医学版), 2023, 55(2): 197-200. |
[15] | 周桥. 肿瘤病理学研究的进展和展望[J]. 北京大学学报(医学版), 2023, 55(2): 201-209. |
|